We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+21.28%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.03B
AUM Growth
+$408M
(+25%)
Cap. Flow
+$76.6M
Cap. Flow
% of AUM
3.78%
Top 10 Holdings %
Top 10 Hldgs %
49.69%
Holding
77
New
15
Increased
27
Reduced
15
Closed
12
Top Buys
| 1 |
AstraZeneca
AZN
|
+$71M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$60.3M |
| 3 |
ALDR
Alder Biopharmaceuticals
ALDR
|
+$44.3M |
| 4 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
+$38.2M |
| 5 |
Insmed
INSM
|
+$37.7M |
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$66.3M |
| 2 |
Elevance Health
ELV
|
+$43.6M |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$35M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$32M |
| 5 |
Penumbra
PEN
|
+$31.5M |
Sector Composition
| 1 | Healthcare | 89.36% |
| 2 | Financials | 3.41% |
| 3 | Communication Services | 0.62% |
| 4 | Energy | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$121B
| $28.7M | 1.42% |
189,008
+44,600
| +31% | +$6.71M |
|
27
iRhythm Holdings
IRTC
$3.72B
| $28.6M | 1.41% |
552,041
+75,700
| +16% | +$3.43M |
|
28
Xencor
XNCR
$1.11B
| $27.5M | 1.36% |
1,200,294
+12,800
| +1% | +$284K |
|
|
LJPC
29
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $25.2M | 1.24% |
723,330
+10,050
| +1% | +$323K |
|
|
EPZM
30
DELISTED
Epizyme, Inc
EPZM
| $23.1M | 1.14% |
+1,210,000
| New | +$18.5M |
|
|
CMRX
31
DELISTED
Chimerix, Inc.
CMRX
| $22.2M | 1.09% |
4,225,575
+18,000
| +0.4% | +$88.6K |
|
|
DPLO
32
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $19.8M | 0.98% |
+957,155
| New | +$16.2M |
|
|
NVTA
33
DELISTED
Invitae Corporation
NVTA
| $19.8M | 0.98% |
2,112,240
+1,300,000
| +160% | +$12.3M |
|
34
Boston Scientific
BSX
$64B
| $17.6M | 0.87% |
603,493
-491,490
| -45% | -$13.6M |
|
|
CBIO
35
Crescent Biopharma
CBIO
$432M
| $17M | 0.84% |
12,141
+6,145
| +102% | +$7.21M |
|
36
Medpace
MEDP
$15.1B
| $15.9M | 0.79% |
499,640
+274,600
| +122% | +$8.39M |
|
|
AMED
37
DELISTED
Amedisys
AMED
| $15.9M | 0.78% |
283,648
+280,292
| +8,352% | +$14.8M |
|
|
JNCE
38
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $14.9M | 0.73% |
955,598
-182,772
| -16% | -$2.58M |
|
|
SYNH
39
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $14M | 0.69% |
267,918
-573,500
| -68% | -$32M |
|
|
CBAY
40
DELISTED
Cymabay Therapeutics
CBAY
| $13.3M | 0.65% |
+1,647,100
| New | +$11.1M |
|
|
LUMO
41
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $12.7M | 0.63% |
+138,744
| New | +$10.6M |
|
|
MODN
42
DELISTED
MODEL N, INC.
MODN
| $12.5M | 0.62% |
838,914
-19,400
| -2% | -$259K |
|
|
DCPH
43
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $12M | 0.59% |
+722,880
| New | +$13.2M |
|
|
ATYR
44
aTyr Pharma
ATYR
$52.4M
| $9.53M | 0.47% |
+134,771
| New | +$6.24M |
|
|
SYRS
45
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $9.44M | 0.47% |
64,142
-33,184
| -34% | -$6.24M |
|
|
CASC
46
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $8.06M | 0.4% |
1,969,969
-1,766,025
| -47% | -$6.76M |
|
47
ProQR Therapeutics
PRQR
$250M
| $7.77M | 0.38% |
1,602,975
+6,700
| +0.4% | +$34.8K |
|
48
Teleflex
TFX
$5.83B
| $7.59M | 0.37% |
+31,365
| New | +$6.82M |
|
49
CytomX Therapeutics
CTMX
$801M
| $6.95M | 0.34% |
382,271
-316,121
| -45% | -$4.93M |
|
|
PETQ
50
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $6.68M | 0.33% |
+246,743
| New | +$5.97M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO